Evidence map›Paper›PMID 29058129›Full record

Observational studySupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2018

Does grip strength decrease in the very early stages of hematological treatment?

C G C Teodozio, G V Chaves, I P Arcuri, F T Frajacomo

Registry-linked trialAbstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03778658 (AYA-UNITE), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03778658 nacompletednot on this mapstarted 2020, after this paper: background citation

AYA-UNITE (Utilizing Novel Information Technology to Promote Exercise and Well-Being)

TypeinterventionalSponsorMilton S. Hershey Medical CenterRan2020 to 2022Enrolled7ConditionsAdolescent, Young Adult, Cancer, Physical ActivityArmsPhysical Activity Intervention
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Early 7-day supplemental parenteral nutrition improves body composition and muscle strength in hypophagic cancer patients at nutritional risk.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019
    Article
  3. Changes in Borg scale for resistance training and test of exercise tolerance in patients undergoing allogeneic hematopoietic stem cell transplantation.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

C G C TeodozioProgram of Molecular Carcinogenesis, Brazilian National Cancer Institute, Andre Cavalcanti Av. 37, Rio de Janeiro, 20231-050, Brazil.
G V ChavesDepartment of Nutrition and Dietetics, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
I P ArcuriDivision of hematology, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
F T FrajacomoProgram of Molecular Carcinogenesis, Brazilian National Cancer Institute, Andre Cavalcanti Av. 37, Rio de Janeiro, 20231-050, Brazil. ffrajacomo@inca.gov.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Muscle weakness in hematological cancer patients undergoing acute stages of treatment is an important concern and strong predictor of poor outcomes. However, evidence of strength loss in the very early stages of cancer treatment is not addressed. Here, we found that grip strength was compromised within the first 7 days of hematological treatment (- 2.3 kg, P = 0.002). These findings are novel in elucidating lower handgrip strength in the first week of hematological treatment and encourage additional research focusing on handgrip strength in oncology patients under initial high-dose chemotherapy routine.

Indexed as

AdolescentAdultAgedFemaleFollow-Up StudiesHand StrengthHematologic NeoplasmsHumansMaleMiddle AgedMuscle StrengthMuscle WeaknessYoung AdultCancerHematologyMuscle strengthPhysical function

Identifiers

PMID29058129

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.